This large cohort study revealed that anti-SMN antibodies were found in > 1 patient only among those with MCTD (11 patients, 36.7%), SLE (20 patients, 10.6%), and SSc (3 patients, 2.4%). Here, SMN1 is linked to systemic sclerosis.